View More
Matthew Gubens, MD, MS, provides expert insight on frontline combination regimens using immunotherapy in advanced NSCLC.
Matthew Gubens, MD, MS
Released: December 30, 2019
Download this PDF resource for patients with advanced NSCLC receiving immune checkpoint inhibitor therapy, including information on what to expect and how to actively participate in their care.
CME-certified Webcast of a CCO symposium at CHEST 2019 featuring expert perspectives on optimal integration of immunotherapy into stage III NSCLC care using a multidisciplinary approach
Gerard A. Silvestri, MD, MS
Kristin Higgins, MD
Mark A. Socinski, MD
Physicians:
maximum of 1.0 AMA PRA Category 1 Credit™
US Physicians:
maximum of 1.0 Medical Knowledge MOC point(s)
Released: November 20, 2019
Expiration: November 19, 2020
In this slideset, experts provide insights on immunotherapy use for stage III NSCLC today and emerging developments in this setting and earlier stages of NSCLC.
Roy S. Herbst, MD, PhD
Melissa L. Johnson, MD
Released: November 8, 2019
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.
CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.